sdj-10154

Initial Sign and Period Until the Diagnosis of Behçet's Diseased Patients in Sulaimani Rheumatology Center

Khanda T. Qadir** , Balkees T. Graib*

* Oral Diagnosis Department, College of Dentistry, University of Sulaimani, Sulaimani, Iraq.

** Kurdistan Board for Medical Specialties, Sulaimani, Iraq.

Submitted: June 10, 2022, Accepted: August 9, 2022, Published: December 1, 2022.

DOI: https://doi.org/10.17656/sdj.10154

Objective: The present study aimed to register the initial clinical findings in BD patients regarding age, sex, and family history as well as to estimate the time lapse until establishing the diagnosis. 

Methods: A descriptive cross-sectional study was implemented to include 50 cases of Behçet's disease over 14 years from the Rheumatology center in Sulaimani governorate-Iraq. Data were tabulated and analyzed by chi-square and independent t-test.      

Results: The sample predominates in females (56%). The male-to-female ratio was 0.78:1. Their ages ranged from 23 to 71 years (43.92 ± 12.02 years). The most affected age group was 41-50 (16 cases, 32%). To a major extent, the first reported sign was oral ulceration (94%); however, the ocular lesion was the first sign in 3 females (6%). Family history was present in relatives of 6 cases (1 male and five females). An average delay of (10.66 ± 6.77) years was noted from the initial manifestation of the first sign to the time of diagnosis.   

Conclusions: Dentists could reduce the delay in Behçet's disease diagnosis because patients in clinical settings may give a history of recurrent oral ulceration with other manifestations that infer possible background of BD.                                                                                     

Keywords:  Behçet's disease, Oral ulceration, The initial sign.         

Full Article - PDF

References:

1. Oguz ID, Hizli P, Gonul M. The epidemiology of Behçet’s disease. Behcet’s disease: InTech. 2017;31:15-26.

2. Koné-Paut I. Behçet's disease in children, an overview. Pediatr Rheumatol. 2016;14(1):1-8.

3. Leonardo NM, McNeil J. Behçet's disease: is there geographical variation? A review far from the Silk Road. Inter J Rheumatol. 2015; 2015. Hindawi Publishing Corporation. 4. Bulur I, Onder M. Behçet disease: new aspects. Clinics in dermatology. 2017;35(5):421-34.

5. Gurler A, Boyvat A, Tursen U. Clinical manifestations of Behçet's disease: an analysis of 2147 patients. Yonsei Med J. 1997;38(6):423-7.

6. Türsen Ü, Türsen B. Treatment options in Behcet’s disease. Glob J Dermatol Venereol. 2014 1;2(1):27-49.

7. Nair JR, Moots RJ. Behcet's disease. Clin Med (London). 2017;17(1):71-7.

8. Faraj SS, Talabani NG. HLA-B51 detection in patients with recurrent aphthus ulceration, an approach for the diagnosis of Behcet's disease in Sulaimani. MSc thesis, College of Dentistry, University of Sulaimani, 2011

9. Gül A, Inanç M, Öcal L, Aral O, Koniçe M. Familial aggregation of Behcet's disease in Turkey. Ann Rheum Dis. 2000;59(8):622-5.

10. Zeidan MJ, Saadoun D, Garrido M, Klatzmann D, Six A, Cacoub P. Behçet's disease physiopathology: a contemporary review. Auto Immun Highlights. 2016;7(1):1-2.

11. Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C, et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease. Nat Genet. 2010;42(8):698-702.

12. Önder M, Gürer MA. The multiple faces of Behçet's disease and its aetiological factors. J Eur Acad Dermatol Venereology. 2001;15(2):126-3.

13. Ideguchi H, Suda A, Takeno M, Ueda A, Ohno S, Ishigatsubo Y. Behçet disease: evolution of clinical manifestations. Medicine (Baltimore). 2011;90(2):125-32.

14. Cho SB, Cho S, Bang D. New insights in the clinical understanding of Behçet's disease. Yonsei Med J. 2012;53(1):35-42.

15. Ishibashi H. What is vascular Behcet's disease?. Ann Vasc Dis. 2018 11(1):52–6.

16. Al-Dhibi H, Abouammoh M, Al-Harthi E, Al- Gaeed A, Larsson J, Abboud E, Chaudhry I. Macular hole in Behcet's disease. Indian J Ophthalmol. 2011;59(5):359.

17. Alpsoy E, Zouboulis CC, Ehrlich GE. Mucocutaneous lesions of Behcet's disease. Yonsei Med J. 2007;48(4):573-85.

18. Davatchi F, Assaad-Khalil S, Calamia KT, Crook JE, Sadeghi-Abdollahi B, Schirmer M, et al. The International Criteria for Behçet's Disease (ICBD): A collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2013;28(3):338-47.

19. Al-Musawi HS, AL-jaryan IL, Tolaifeh ZA. Behçet's Disease: A Clinical Review. J Univ Babylon Pure Appl Sci. 2020;28(2):172-89.

20. Yazici H, Tüzün Y, Pazarli H, Yurdakul S, Ozyazgan Y, Ozdoğan H, et al. Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behcet's syndrome. Ann Rheum Dis. 1984;43(6):783-9.

21. Davatchi F, Shahram F, Chams C, Nadji HC. Behçet's disease. Acta Medica Iranica. 2005;43(4):233-42.

22. Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, et al. The long-term mortality and morbidity of Behçet syndrome: a 2- decade outcome survey of 387 patients followed at a dedicated center. Medicine. 2003;82(1):60-76.

23. Sula B, Batmaz I, Ucmak D, Yolbas I, Akdeniz S. Demographical and clinical characteristics of Behcet's disease in Southeastern Turkey. J Clin Med Res. 2014;6(6):476.

24. Ozyurt K, Colgecen E, Baykan H. Does familial occurance or family history of recurrent oral ulcers affects clinical characteristics of Behçet's disease?. Acta Dermatovenerol Croat. 2013 ;21(3):168-73.

25. Bodis G, Toth V, Schwarting A. Role of human leukocyte antigens (HLA) in autoimmune diseases. Rheumatol Ther. 2018;5(1):5-20.

26. Kontogiannis V, Powell RJ. Behçet's disease. Postgrad Med J. 2000;76(900):629-37.

27. Kitaichi N, Miyazaki A, Iwata D, Ohno S, Stanford MR, Chams H. Ocular features of Behçet's disease: an international collaborative study. Br J Ophthalmol. 2007 1;91(12):1579-82.

28. Posarelli C, Maglionico MN, Talarico R, Covello G, Figus M. Behçet's syndrome and ocular involvement: changes over time. Clin Exp Rheumatol. 2020;38(127):86-93.

29. Sungur G, Hazirolan D, Hekimoglu E, Kasim R, Duman S. Late-onset Behçet's disease: demographic, clinical, and ocular features. Graefe's Arch Clin Exp Ophthalmol. 2010;248(9):1325-30.

30. Alpsoy E, Donmez L, Onder M, Gunasti S, Usta A, Karincaoglu Y, et al. Clinical features and natural course of Behçet's disease in 661 cases: a multicentre study. Br J Dermatol. 2007;157(5):901-6.

Abstract